Trial
NCT03415581
Evaluation of Doxazosin to Alter the Abuse of Oxycodone
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
—
Condition
Opioid-use Disorder
Intervention
Intranasal Oxycodone
Why stopped
Study terminated by sponsor due to bad risk/benefit ratio.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-12